Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Zhixiang ChenLei ZhaBin HuBin XuLin ZuoJun YangZhuhua Chu Lingling MaFangfang Hu

Published in: Canadian respiratory journal (2024)

The serum ChE level was correlated significantly with complicating severe hypoxemia, hypercapnia, prolonged DoHS, and the need for NIV in patients hospitalized with AECOPD. The serum ChE level is a clinically important risk-stratification biomarker in patients hospitalized with AECOPD.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
cystic fibrosis
patient reported outcomes
liver failure
early onset
drug induced